Lord Mendelsohn

To ask Her Majesty's Government whether they have benchmarked the way that that the list of those selected for enhanced security checks by US Homeland Security at UK sites is compiled; and whether they have compared this with any other countries in which ...

To ask Her Majesty's Government what assurances they have received from the government of the United States that the permitted airport Homeland Security checks are random and not based on racial and other profiling.

To ask Her Majesty's Government what assurances they have received from the US ambassador to the UK on the operation of the Homeland Security checks on UK territory; and when was the last time such checks were discussed by UK Ministers.

To ask Her Majesty's Government what verification checks are conducted on the permitted US Homeland Security procedures at UK airports; who conducts these checks; in which department the people that conduct these checks are based; and when was the last ti...

To ask Her Majesty's Government who is producing the data on how many (1) immunocompromised, or (2) immunosuppressed, people have received their fourth dose of the COVID-19 vaccine; and where it will be published.

To ask Her Majesty's Government when data on how many (1) immunocompromised, or (2) immunosuppressed, people have received a fourth dose of COVID-19 vaccine will be available.

To ask Her Majesty's Government what plans they have to make lateral flow tests available free of charge to people (1) on low incomes, or (2) on benefits, to help address health inequalities.

To ask Her Majesty's Government what plans, if any, they have to introduce preventative antibody therapies to mitigate the risks of COVID-19 for clinically extremely vulnerable individuals.

To ask Her Majesty's Government what plans they have to continue to provide free lateral flow tests to people who are clinically extremely vulnerable so that this group can benefit from COVID-19 antiviral therapies within the necessary period for such the...

To ask Her Majesty's Government how much Evusheld monoclonal antibody treatment they have secured; and when this treatment will be available to the clinically vulnerable in the UK.

To ask Her Majesty's Government how many courses of (1) antiviral, and (2) monoclonal, antibody treatments for COVID-19 are (a) currently held by NHS England, and (b) secured via new contracts.

To ask Her Majesty's Government what steps they will take to support those who are clinically extremely vulnerable who have been shielding during the COVID-19 pandemic and are now suffering with their mental health.

To ask Her Majesty's Government how many (1) immunocompromised, or (2) immunosuppressed, people have received their fourth dose of the COVID-19 vaccine.

To ask Her Majesty's Government how many (1) immunocompromised, or (2) immunosuppressed, people have received (a) antiviral, or (b) monoclonal, antibody treatments for COVID-19.

To ask Her Majesty's Government how many clinically extremely vulnerable people have received their fourth dose of the COVID-19 vaccine.

To ask Her Majesty's Government how many people who are immunocompromised or immunosuppressed have received a third dose of a COVID-19 vaccine in England to date.

To ask Her Majesty's Government what plans they have to protect the (1) primary, and (2) secondary, immunodeficiency community against COVID-19 this winter.

To ask Her Majesty's Government what changes they have made to the commissioning eligibility criteria for immunoglobulin use since the identification of a shortage of immunoglobulin; and (1) when, and (2) how, these will be implemented.

To ask Her Majesty's Government how much the NHS has invested in multi-parametric magnetic resonance imaging scanners in the last three years.

To ask Her Majesty's Government how many multi-parametric magnetic resonance imaging scans are in use in each Cancer Alliance.